Phase 1Completed

A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)

A Clinical Study to Evaluate the Effect of Enlicitide on the Pharmacokinetics of Lithium in Healthy Adult Participants

Sponsor
Merck Sharp & Dohme LLC (Industry)
Enrollment
16 enrolled
Conditions
Healthy
Interventions
lithium carbonate; enlicitide
Ages
adults
Registry
NCT06719544

Full record on ClinicalTrials.gov

From the registry

Researchers have designed a new study medicine called enlicitide decanoate (MK-0616) as a new way to lower the amount of low-density lipoprotein cholesterol (LDL-C) in a person's blood. Enlicitide decanoate will be called "enlicitide" from this point forward. Lithium (also called lithium carbonate) is a medicine used in bipolar disorder. Researchers want to learn about lithium when taken at the same time with enlicitide. They want to: * Measure a person's blood to find out if the amount of lithium in the blood is the same when lithium is taken alone or with enlicitide * Learn about the safety of lithium when taken alone or with enlicitide and if people tolerate it

Primary outcomes

  • Area Under the Concentration Versus Time Curve From Time Zero to Infinity (AUC0-inf) for Lithium in Plasma
  • Area Under the Concentration versus Time Curve From Time Zero to Last Quantifiable Sample (AUC0-last) for Lithium in Plasma
  • Cmax (Maximum Concentration) for Lithium in Plasma

History

  1. Last registry update

  2. Study completion

  3. Primary completion

  4. Started

  5. Registered